We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

CERTEST BIOTEC

Certest Biotec, S.L. develops and manufactures IVD products in the human clinical testing field, including rapid test... read more Featured Products: More products

Download Mobile App




Real-Time PCR Kit Enables Specific Identification and Differentiation of Rhinovirus and/or Enterovirus

By LabMedica International staff writers
Posted on 21 Jul 2023

Echovirus 11 (E-11), part of the Enterovirus genus, is associated with a variety of health conditions, from mild non-specific symptoms to severe systemic and neurological disorders like skin rashes, fever, meningitis, encephalitis, and acute flaccid paralysis (AFP). More...

It poses a significant threat to neonates and infants, leading to high rates of illness and death. E-11 can be transmitted from mother to child, making infection control a challenge. In neonates, these infections can cause severe inflammatory diseases, including acute hepatitis with coagulopathy.

Without a global enterovirus surveillance program, estimating the current prevalence of severe neonatal E-11 infections or the virus's circulation rate in the population is difficult. Only the most severe cases are likely to be detected through active sample testing and typing efforts without enterovirus surveillance. Furthermore, there may be unreported and undiagnosed cases of severe neonatal enterovirus infection since non-polio enterovirus infection is often not a reportable disease. Now, a real-time PCR test can quickly and accurately identify as well as differentiate Rhinovirus and/or Enterovirus, allowing for personalized treatment and proper medical care.

CerTest Biotec’s (Zaragoza, Spain) VIASURE Rhinovirus + Enterovirus real-time PCR kit is specifically designed for the identification and differentiation of Rhinovirus and/or Enterovirus. The primer/probe design enables the detection of Enterovirus (Echovirus-11 (E-11)), facilitating early and precise diagnosis of this viral infection. The qPCR (real-time PCR) method is highly sensitive and specific, delivering reliable and accurate results quickly. The VIASURE kit offers considerable benefits in diagnosing Rhinovirus and Enterovirus infections. By specifically detecting Echovirus-11, it aids in distinguishing it from other Enterovirus family members, ensuring a more comprehensive and accurate infection assessment.

Early detection of Echovirus-11 is vital for appropriate and timely clinical management of affected patients. This includes identifying outbreaks, isolating and treating affected cases adequately, and monitoring the virus spread to implement effective control and preventive measures. Moreover, the test’s ability to differentiate between Rhinovirus and Enterovirus is invaluable as these two virus families can present similar symptoms, but their clinical implications and treatments could vary. Accurate diagnosis allows for more personalized and appropriate patient care. The VIASURE Rhinovirus + Enterovirus real-time PCR kit serves as a crucial tool for rapid and precise viral infection diagnosis, especially in Echovirus-11 cases, significantly contributing to efficient public health and healthcare management.

Related Links:
CerTest Biotec


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Multilevel Whole Blood Calibrator Set
6PLUS1
New
Urine Drug Test
Instant-view® Phencyclidine Urine Drug Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Microbiology

view channel
Image: The U.S. FDA-cleared IntelliSep rapid host response diagnostic represents a breakthrough in sepsis care (Photo courtesy of Cytovale)

Rapid Diagnostic Test Slashes Sepsis Mortality by 39%

Sepsis remains one of the most challenging and fatal conditions in contemporary healthcare, accounting for nearly one-third of all hospital-related deaths in the United States. In emergency departments... Read more

Industry

view channel
Image: The knowledge transfer partnership will further develop technology to rapidly diagnose serious and high-risk infectious diseases (Photo courtesy of Aston University)

Aston University and BG Research Partner to Commercialize Groundbreaking Medical Diagnostic

Technology that can rapidly diagnose high-consequence infectious diseases will take a major step forward towards commercialization, thanks to a new partnership. A Knowledge Transfer Partnership (KTP)... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.